Live at IDWeek 2013

Live at IDWeek 2013

High Completion Rate with 3-Month Isoniazid + Rifapentine Regimen for Latent Tuberculosis

The completion rate of a 12-dose, 3-month isoniazid/rifapentine (3HP) regimen in this study (83.7%) is comparable to its completion rate in Study 26 (82.1%), and is significantly higher than the average 55.0% completion rate for the 9-month isoniazid regimen that was reported in Arkansas for the past 5 years, according to results presented at IDWeek 2013.